These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 6773171)
1. The interrelationship between thromboxane biosynthesis, aggregation and 5-hydroxytryptamine secretion in human platelets in vitro. Best LC; Holland TK; Jones PB; Russell RG Thromb Haemost; 1980 Feb; 43(1):38-40. PubMed ID: 6773171 [TBL] [Abstract][Full Text] [Related]
2. Effect of the polyamine-spermine on agonist-induced human platelet activation--specific inhibition of "aggregation-independent" events induced by thrombin, but not by collagen, thromboxane mimetic, phorbol ester or calcium ionophore. Joseph S; Krishnamurthi S; Kakkar VV Thromb Haemost; 1987 Apr; 57(2):191-5. PubMed ID: 3110996 [TBL] [Abstract][Full Text] [Related]
3. Studies on the role of calcium in the control of thromboxane B2 production. Best LC; Bone EA; Jones PB; Russell RG Artery; 1980; 8(5):487-93. PubMed ID: 6783015 [TBL] [Abstract][Full Text] [Related]
4. Effect of pyridoxal 5'-phosphate (PALP) on human platelet aggregation, dense granule release and thromboxane B2 generation--role of Schiff base formation. Krishnamurthi S; Westwick J; Kakkar VV Thromb Haemost; 1982 Oct; 48(2):136-41. PubMed ID: 6891107 [TBL] [Abstract][Full Text] [Related]
5. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion. Hornby EJ; Foster MR; McCabe PJ; Stratton LE Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661 [TBL] [Abstract][Full Text] [Related]
6. Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery. Zimmermann N; Wenk A; Kim U; Kienzle P; Weber AA; Gams E; Schrör K; Hohlfeld T Circulation; 2003 Aug; 108(5):542-7. PubMed ID: 12874188 [TBL] [Abstract][Full Text] [Related]
7. Effect of cholesterol on production of thromboxane b2 by platelets in vitro. Stuart MJ; Gerrard JM; White JG N Engl J Med; 1980 Jan; 302(1):6-10. PubMed ID: 7350406 [TBL] [Abstract][Full Text] [Related]
8. Indirect actions of thapsigargin on human platelets: activation of eicosanoid biosynthesis and cellular signaling pathways. Malcolm KC; Fitzpatrick FA J Pharmacol Exp Ther; 1992 Mar; 260(3):1244-9. PubMed ID: 1532033 [TBL] [Abstract][Full Text] [Related]
9. Thromboxane B2 production and lipid peroxidation in human blood platelets. Best LC; Jones PB; McGuire MB; Russell RG Adv Prostaglandin Thromboxane Res; 1980; 6():297-9. PubMed ID: 7386271 [No Abstract] [Full Text] [Related]
10. Effects of mitoxantrone and bisantrene on platelet aggregation and prostaglandin/thromboxane biosynthesis in vitro. Frank P; Novak RF Anticancer Res; 1986; 6(5):941-7. PubMed ID: 3467648 [TBL] [Abstract][Full Text] [Related]
11. A major role of ADP in thromboxane transfer experiments: studies in patients with platelet secretion defects. Rao AK; Willis J; Holmsen H J Lab Clin Med; 1984 Jul; 104(1):116-26. PubMed ID: 6429260 [TBL] [Abstract][Full Text] [Related]
12. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903 [TBL] [Abstract][Full Text] [Related]
13. Megakaryocyte thromboxane production induced by platelet stimuli during in vitro culture. Walenga RW; Miller JL; Stuart MJ Exp Hematol; 1985 Feb; 13(2):87-91. PubMed ID: 3918879 [TBL] [Abstract][Full Text] [Related]
14. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation. Vezza R; Nenci GG; Gresele P J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121 [TBL] [Abstract][Full Text] [Related]
15. Failure of preactivated human blood platelets to restore defective thromboxane synthesis despite prolonged incubation in plasma. Stockschläder M; Scharf RE Thromb Haemost; 1989 Nov; 62(3):1016-22. PubMed ID: 2512674 [TBL] [Abstract][Full Text] [Related]
16. Effect of physiologic shear stresses and calcium on agonist-induced platelet aggregation, secretion, and thromboxane A2 formation. Viisoreanu D; Gear A Thromb Res; 2007; 120(6):885-92. PubMed ID: 17306868 [TBL] [Abstract][Full Text] [Related]
17. Amplification of primary response of human platelets to platelet-activating factor: aspirin-sensitive and aspirin-insensitive pathways. Lauri D; Cerletti C; de Gaetano G J Lab Clin Med; 1985 Jun; 105(6):653-8. PubMed ID: 3923145 [TBL] [Abstract][Full Text] [Related]
18. [Effects of isosorbide dinitrate on platelet aggregation and production of thromboxane B2]. De Caterina R; Crea F; Giannessi D; Bernini W; Gazzetti P; Chierchia S; Distante A; L'Abbate A Cardiologia; 1982; 27(3):315-7. PubMed ID: 6892461 [No Abstract] [Full Text] [Related]
19. Effect of thromboxane synthetase inhibition on platelet function and morphology during ovine pregnancy-induced hypertension. Miller KW; Keith JC Thromb Haemost; 1988 Dec; 60(3):365-71. PubMed ID: 3238644 [TBL] [Abstract][Full Text] [Related]
20. Mepacrine blockade of arachidonate-induced washed platelet aggregation: relationship to mepacrine inhibition of platelet cyclooxygenase. Raz A Thromb Haemost; 1983 Dec; 50(4):784-6. PubMed ID: 6420923 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]